The global naltrexone market is entering a steady-growth phase as healthcare systems place greater emphasis on addiction treatment, rehabilitation, and long-term recovery. Valued at US$ 21.0 Bn in 2023, the market is expected to grow at a 3.6% CAGR between 2024 and 2034, reaching US$ 30.8 Bn by 2034.👉 Get sample market research report copy...